Tifluadom is undoubtedly an atypical benzodiazepine with practically no activity within the GABA-A receptors. This helps make this drug totally distinctive from 90% of your benzodiazepine family. Regrettably, there isn’t much official research on this compound since the drug never made it to current market. Tingjunhong Ni et al. synthesized twe